EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
news

Oral antibiotic shows promise to cure uncomplicated gonorrhea

An investigational oral antibiotic called zoliflodacin was well-tolerated and successfully cured most cases of uncomplicated gonorrhea when tested in a Phase 2 multic...
Continue Reading →
news

High-impact clinical trial results could affect kidney-related medical care

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented at ASN Kidney Week 2018 October 23-October 28 at t...
Continue Reading →
Asia Pacific

New drug kills antibiotic-resistant bacteria in clinical trial

Antibiotic resistance is a major obstacle that modern medicine is currently grappling with. It has created crisis situations around the world, and researchers are try...
Continue Reading →
Europe

Pivotal Trial Confirms Long-Term Safety and Efficacy of IV Iron Dosing Strategy

Results from the PIVOTAL trial were presented during the High-Impact Clinical Trials session at American Society of Nephrology (ASN) Kidney Week 2018 The tria...
Continue Reading →
Europe

Immunotherapy may become new first line treatment in some metastatic colorectal cancers

Immunotherapy with nivolumab and low-dose ipilimumab could become a new first line treatment in patients with some metastatic colorectal cancers following late-breaki...
Continue Reading →
news

FDA approves asthma indication for Dupixent® (dupilumab)

Only biologic approved for both moderate and severe asthma patients with eosinophilic phenotype Only biologic approved for oral corticosteroid-dependent asthma, ...
Continue Reading →
Europe

Nanobiotix: Positive Phase II / III Results for NBTXR3 in Soft Tissue Sarcoma Presented at ESMO

Dr. Sylvie Bonvalot, Head of Sarcoma and Complex Tumor Surgery Unit at Institut Curie - Paris, presented first-in-class NBTXR3 positive Phase II/III results during...
Continue Reading →
news

Orion and Bayer have completed the phase III trial of darolutamide in patients with non-metastatic castration-resistant prostate cancer – The primary endpoint was met

Orion and Bayer have completed the phase III clinical trial (ARAMIS) of darolutamide, the novel oral androgen receptor antagonist for the treatment of patients with n...
Continue Reading →
news

PCI Pharma Services Completes Acquisition of Sherpa Clinical Packaging

PCI continues expansion of its global clinical services network to California. Philadelphia, USA – October 2, 2018 Leading global biopharmaceutical outsourcing servic...
Continue Reading →
news

New blood test for pediatric brain tumor patients offers safer approach than surgical biopsies

A new blood test for children with brain tumors offers a safer approach than surgical biopsies and may allow doctors to measure the effectiveness of treatment even be...
Continue Reading →
Quotient